Open-label Study of Flexible-dose Paliperidone ER (Extended Release) to Treat Adolescent Schizophrenia.
Status:
Completed
Trial end date:
2012-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this open-label study is to evaluate the long-term (6-month) safety and
tolerability of extended-release paliperidone, an atypical antipsychotic, given in flexible
dosages to adolescents with schizophrenia.